ESC Premium Access

Increased bleeding events in patients co-administered rivaroxaban and either cyp3A4 or p-gp inhibitors

Congress Presentation

About the speaker

Doctor Jeffrey Michel

Baylor Scott and White Health, Austin (United States of America)
0 follower

4 more presentations in this session

State of the Art: oral anticoagulation in the challenging patient

Speaker: Professor P. Kirchhof (Hamburg, DE)


Use of aspirin and impact of quality of anticoagulation control on outcomes in patients with atrial fibrillation: an analysis from the SPORTIF trials

Speaker: Doctor M. Proietti (Milan, IT)


Clinical determinants of time in therapeutic range and the role of SAMe-TT2R2 score in atrial fibrillation patients receiving oral anticoagulation: data from FANTASIIA registry.

Speaker: Doctor M. Esteve Pastor (Murcia, ES)


The future of oral anticoagulation

Speaker: Doctor J. Weitz (Hamilton, CA)


Access the full session

How to make oral anticoagulation safe

Speakers: Doctor J. Michel, Professor P. Kirchhof, Doctor M. Proietti, Doctor M. Esteve Pastor, Doctor J. Weitz

About the event


ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb